Full Professor(heuristic)

Cancer Genomics and Diagnostics · Cancer Research

Compare more Cancer Research professors.

h-index141
i10-index396
Publications1,836
Citations86,180

Grants

11 total · 4 active

NIH #R01CA309345

HER2 PET imaging to assess HER2 heterogeneity and predict response to HER2-targeted therapy in biliary tract cancer

Active
Amount
$700K–$800K
Period
2026-04-01 → 2031-03-31
PIs
3

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #R01CA296335

The Role of EP300 Mutations in Bladder Cancer Pathogenesis and Drug Response

Active
Amount
$500K–$600K
Period
2025-01-01 → 2029-12-31
PIs
2

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #R01CA288692

HER2 PET imaging to assess HER2 heterogeneity and predict response to HER2-targeted ADC therapy in urothelial carcinoma

Active
Amount
$500K–$600K
Period
2024-04-01 → 2029-03-31
PIs
3

Awarded at SLOAN-KETTERING INST CAN RESEARCH

Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →

All Grants

11 total · 4 active

NIH #R01CA309345

HER2 PET imaging to assess HER2 heterogeneity and predict response to HER2-targeted therapy in biliary tract cancer

Active
Amount
$700K–$800K
Period
2026-04-01 → 2031-03-31
PIs
3

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #R01CA296335

The Role of EP300 Mutations in Bladder Cancer Pathogenesis and Drug Response

Active
Amount
$500K–$600K
Period
2025-01-01 → 2029-12-31
PIs
2

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #R01CA288692

HER2 PET imaging to assess HER2 heterogeneity and predict response to HER2-targeted ADC therapy in urothelial carcinoma

Active
Amount
$500K–$600K
Period
2024-04-01 → 2029-03-31
PIs
3

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #P50CA092629

Project 1: Genomic Predictors of Clinical Outcomes and Response to Targeted Therapy in Advanced Prostate Cancer

Active
Amount
$300K–$400K
Period
2001-09-14 → 2027-08-31
PIs
1

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #P01CA228696

Genomics Core

Amount
$500K–$600K
Period
2019-09-01 → 2025-08-31
PIs
1

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #P01CA221757

Project 1: Role of the H3K27 demethylase KDM6A in bladder cancer pathogenesis

Amount
$400K–$500K
Period
2018-09-11 → 2024-08-31
PIs
1

Awarded at COLUMBIA UNIVERSITY HEALTH SCIENCES

NIH #R01CA234361

Defining mechanisms of resistance to hormonal therapy in breast cancer

Amount
$400K–$500K
Period
2018-12-05 → 2023-11-30
PIs
2

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #P50CA221745

SPORE in Bladder Cancer

Amount
$2M–$3M
Period
2018-08-24 → 2023-07-31
PIs
2

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #R01CA229624

Development of optimal strategies to inhibit ERK signaling in tumors with RAF and MEK mutations

Amount
$400K–$500K
Period
2018-06-14 → 2023-05-31
PIs
1

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #R01CA207244

Targeting AKT-Mutant Human Cancers

Amount
$400K–$500K
Period
2016-07-05 → 2021-06-30
PIs
1

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #U54OD020355

MSKCC Pilot Center for Precision Disease Modeling

Amount
$2M–$3M
Period
2015-08-01 → 2021-06-30
PIs
2

Awarded at SLOAN-KETTERING INST CAN RESEARCH

Recent Public Signals

  1. New paper: Molecular and Clinical Determinants of Targeted Therapy Treatment in Biliary Tract Cancer (Clinical Cancer Research)2026-06-26
  2. New preprint: Integrated Clinicogenomic Risk Modeling for Metachronous Second Primary Cancers2026-06-22
  3. New NIH award: HER2 PET imaging to assess HER2 heterogeneity and predict response to HER2-targeted therapy in biliary tract cancer2026-04-01

Are you this professor?

No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.

Data Freshness

  • Publications as of 2026-07-09
  • Grants as of 2026-09-03

Data may not be current

Find elsewhere

Institution / lab homepage Search on ResearchGate

ORCID: 0000-0002-6614-802X

Professor Insights

Career Trajectory